Thoratec Corporation

Skip to content

Overview

Webcast ImageWebcast
Q3 2014 Thoratec Corporation Earnings Conference Call (Live)
11/05/14 at 1:30 p.m. PT
THOR (Common Stock)
Price27.18Change+ 0.78
Volume873,744% Change2.95%
10/31/2014 4:00 p.m. ETPricing delayed 20 minutes

Thoratec is the world leader in mechanical circulatory support with the broadest product portfolio to treat the full range of clinical needs for patients suffering from advanced heart failure. The company's products include the HeartMate LVAS and Thoratec VAD, with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag and PediMag / PediVAS product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit www.thoratec.com.

Recent News

More >>
DateTitle 
10/15/14Thoratec Schedules Third Quarter Conference Call, Webcast
PLEASANTON, Calif., Oct. 15, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter of fiscal year 2014 on Wednesday, November 5. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Standard Time ... 
Printer Friendly Version
10/06/14Thoratec Announces Additions To Senior Management Team
PLEASANTON, Calif., Oct. 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that Niamh Pellegrini has joined Thoratec in the new role of President, North America.     This new position at Thoratec encompasses responsibility for all commercial operations within North America.  Ms. Pellegrini has over twenty-five years of experience in the healthcare ind... 
Printer Friendly Version
09/22/14Thoratec Appoints D. Keith Grossman President And Chief Executive Officer
COMPANY PROVIDES THIRD QUARTER FINANCIAL UPDATES PLEASANTON, Calif., Sept. 22, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that D. Keith Grossman has been appointed President and Chief Executive Officer, effective immediately.  Mr. Grossman succeeds Gary F. Burbach, who has stepped down from his executive and Board roles but will remain as an advis... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.